Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 181 to 185 of 185 entries
Sorted by: Best Match Show Resources per page
β-adrenoceptor antagonists and nightmares: A pharmacoepidemiological-pharmacodynamic study.

Journal of psychopharmacology (Oxford, England)

Garcia P, Montastruc JL, Rousseau V, Hamard J, Sommet A, Montastruc F.
PMID: 34318729
J Psychopharmacol. 2021 Dec;35(12):1441-1448. doi: 10.1177/02698811211034810. Epub 2021 Jul 28.

AIM: To compare different β-adrenoceptor antagonists for the risk of reporting nightmare.METHODS: The study involved two approaches: first, we investigated in VigiBaseRESULTS: Of the 126,964 reports recorded with β-adrenoceptor antagonists, 1138 (0.9%) were nightmares. The highest risk of reporting...

Impact of the presence of a median lobe on functional outcomes of greenlight photovaporization of the prostate (PVP): an analysis of the Global Greenlight Group (GGG) Database.

World journal of urology

Nguyen DD, Sadri I, Law K, Bhojani N, Elterman DS, Zakaria AS, Arezki A, Bruyère F, Cindolo L, Ferrari G, Vasquez-Lastra C, Borelli-Bovo T, Becher EF, Cash H, Reimann M, Rijo E, Misrai V, Zorn KC.
PMID: 33388918
World J Urol. 2021 Oct;39(10):3881-3889. doi: 10.1007/s00345-020-03529-w. Epub 2021 Jan 03.

OBJECTIVES: Previous analyses of the impact of median lobe presence on Greenlight photoselective vaporization of the prostate (PVP) outcomes were limited by their small sample size and the ability to adjust for important confounders. As such, we sought to...

Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

De Nunzio C, Lombardo R, Baldassarri V, Cindolo L, Bertolo R, Minervini A, Sessa F, Muto G, Bove P, Vittori M, Bozzini G, Castellan P, Mugavero F, Falsaperla M, Schips L, Celia A, Bada M, Porreca A, Pastore A, Al Salhi Y, Giampaoli M, Novella G, Rizzetto R, Trabacchin N, Mantica G, Pini G, Remmers S, Antonelli A, Tubaro A.
PMID: 33965292
Eur J Surg Oncol. 2021 Oct;47(10):2640-2645. doi: 10.1016/j.ejso.2021.04.033. Epub 2021 Apr 30.

OBJECTIVES: The Rotterdam Prostate Cancer Risk calculator (RPCRC) has been validated in the past years. Recently a new version including multiparametric magnetic resonance imaging (mpMRI) data has been released. The aim of our study was to analyze the performance...

Environmental Safety of the 180-W GreenLight Laser: A Pilot Study On Plume And Irrigating Fluids.

Urology

Ferrari G, Ferrari AM, Campobasso D, Modenese A, Rijo E, Misrai V, Rosa R, Cindolo L.
PMID: 33785403
Urology. 2021 Aug;154:227-232. doi: 10.1016/j.urology.2021.03.016. Epub 2021 Mar 27.

OBJECTIVE: To analyze the chemical composition of the surgical smoke and the outflow irrigation fluid produced during a common endourological surgical procedure to treat benign prostatic obstruction (BPO).METHODS: A prospective study was performed to analyze the surgical smoke generated...

Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis.

Therapeutic advances in urology

Mari A, Antonelli A, Cindolo L, Fusco F, Minervini A, De Nunzio C.
PMID: 33912246
Ther Adv Urol. 2021 Apr 12;13:1756287221993283. doi: 10.1177/1756287221993283. eCollection 2021.

BACKGROUND: Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) are a bothersome frequent symptom in adult males. This systematic review analyzed the available evidence on the pharmacokinetic and pharmacodynamic features of alfuzosin, and its clinical efficacy...

Showing 181 to 185 of 185 entries